Inhibition of p56lckTyrosine Kinase by Isothiazolones
- 1 April 1999
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 364 (1) , 19-29
- https://doi.org/10.1006/abbi.1999.1099
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- αβ T Cell Development Is Abolished in Mice Lacking Both Lck and Fyn Protein Tyrosine KinasesImmunity, 1996
- HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression.Journal of Clinical Investigation, 1996
- Redox modulation of tyrosine phosphorylation-dependent signal transduction pathwaysFree Radical Biology & Medicine, 1996
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase InhibitorJournal of Biological Chemistry, 1996
- Approach to the discovery of novel, selective inhibitors of p56lck tyrosine kinase: Identification of non‐hydroxylated chromones as p56lck inhibitorsDrug Development Research, 1995
- Inhibition of T Lymphocyte Actnation by a Novel p56lckTyrosine Kinase InhibitorJournal of Enzyme Inhibition, 1995
- Tyrosine Kinase Inhibitors. 3. Structure-Activity Relationships for Inhibition of Protein Tyrosine Kinases by Nuclear-Substituted Derivatives of 2,2'-Dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide)Journal of Medicinal Chemistry, 1994
- Signal transduction by lymphocyte antigen receptorsCell, 1994
- Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptorCell, 1992
- The Ick tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domainCell, 1989